Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 509420, 5 pages
http://dx.doi.org/10.1155/2012/509420
Research Article

Associations of Polymorphisms in the Apolipoprotein APOA1-C3-A5 Gene Cluster with Acute Coronary Syndrome

1Hubei Provincial Key Laboratory of Embryonic Stem Cell Research, Tai He Hospital, Hubei University of Medicine, 32 S. Renmin Road, Shiyan, Hubei 442000, China
2Clinical Laboratory, Tai He Hospital, Hubei University of Medicine, 32 S. Renmin Road, Shiyan, Hubei 442000, China
3Cardiovascular Department, Taihe Hospital, Hubei University of Medicine, 32 S. Renmin Road, Shiyan, Hubei 442000, China

Received 10 February 2012; Revised 8 March 2012; Accepted 22 March 2012

Academic Editor: Momiao Xiong

Copyright © 2012 Yan Ding et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. I. M. Stylianou, R. C. Bauer, M. P. Reilly, and D. J. Rader, “Genetic basis of atherosclerosis: insights from mice and humans,” Circulation Research, vol. 110, no. 2, pp. 337–355, 2012. View at Google Scholar
  2. W. R. Maclellan, Y. Wang, and A. J. Lusis, “Systems-based approaches to cardiovascular disease,” Nature Reviews Cardiology, vol. 9, no. 3, pp. 172–184, 2012. View at Google Scholar
  3. M. Miller, C. P. Cannon, S. A. Murphy, J. Qin, K. K. Ray, and E. Braunwald, “Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial,” Journal of the American College of Cardiology, vol. 51, no. 7, pp. 724–730, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Pennacchio, M. Olivier, J. A. Hubacek et al., “An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing,” Science, vol. 294, no. 5540, pp. 169–173, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. S. C. Hamon, S. L. R. Kardia, E. Boerwinkle et al., “Evidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 gene cluster,” Human Heredity, vol. 61, no. 2, pp. 87–96, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. Q. F. Wang, X. Liu, J. O'Connell et al., “Haplotypes in the APOA1-C3-A4-A5 gene cluster affect plasma lipids in both humans and baboons,” Human Molecular Genetics, vol. 13, no. 10, pp. 1049–1056, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. G. T. Russo, J. B. Meigs, L. A. Cupples et al., “Association of the Sst-I polymorphism at the APOC3 gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: the Framingham offspring study,” Atherosclerosis, vol. 158, no. 1, pp. 173–181, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. P. J. Talmud, E. Hawe, S. Martin et al., “Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides,” Human Molecular Genetics, vol. 11, no. 24, pp. 3039–3046, 2002. View at Google Scholar · View at Scopus
  9. E. Olano-Martin, E. C. Abraham, R. Gill-Garrison et al., “Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender,” Journal of Lipid Research, vol. 49, no. 5, pp. 945–953, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. D. M. Hallman, S. R. Srinivasan, W. Chen, E. Boerwinkle, and G. S. Berenson, “Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study,” Metabolism, vol. 55, no. 12, pp. 1574–1581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. M. I. Kamboh, C. E. Aston, C. M. Nestlerode, A. E. McAllister, and R. F. Hamman, “Haplotype analysis of two APOA1/MspI polymorphisms in relation to plasma levels of Apo A-I and HDL-cholesterol,” Atherosclerosis, vol. 127, no. 2, pp. 255–262, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Mälarstig, T. Tenno, N. Johnston et al., “Genetic variations in the tissue factor gene are associated with clinical outcome in acute coronary syndrome and expression levels in human monocytes,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 25, no. 12, pp. 2667–2672, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Matsunaga, H. Arishima, H. Niimura et al., “Strong linkage disequilibrium and association of -1131T>C and c.553G>T polymorphisms of the apolipoprotein A5 gene with hypertriglyceridemia in a Japanese populatio,” Circulation Journal, vol. 71, no. 5, pp. 746–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. K. Heng, P. S. Low, and N. Saha, “Variations in the promoter region of the apolipoprotein A-1 gene influence plasma lipoprotein(a) levels in Asian Indian neonates from Singapore,” Pediatric Research, vol. 49, no. 4, pp. 514–518, 2001. View at Google Scholar · View at Scopus
  15. S. Taş, “Strong association of a single nucleotide substitution in the 3'-untranslated region of the apolipoprotein-CIII gene with common hypertriglyceridemia in Arabs,” Clinical Chemistry, vol. 35, no. 2, pp. 256–259, 1989. View at Google Scholar · View at Scopus
  16. C. K. Glass and J. L. Witztum, “Atherosclerosis: the road ahead,” Cell, vol. 104, no. 4, pp. 503–516, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Qi, S. Liu, N. Rifai, D. Hunter, and F. B. Hu, “Associations of the apolipoprotein A1/C3/A4/A5 gene cluster with triglyceride and HDL cholesterol levels in women with type 2 diabetes,” Atherosclerosis, vol. 192, no. 1, pp. 204–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Shanker, G. Perumal, V. S. Rao et al., “Genetic studies on the APOA1-C3-A5 gene cluster in Asian Indians with premature coronary artery disease,” Lipids in Health and Disease, vol. 7, article 33, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. R. X. Yin and C. Q. Lai, “Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels,” Lipids in Health and Disease, vol. 10, article 140, 2011. View at Google Scholar
  20. K. L. Chien, M. F. Chen, H. C. Hsu et al., “Genetic association study of APOA1/C3/A4/A5 gene cluster and haplotypes on triglyceride and HDL cholesterol in a community-based population,” Clinica Chimica Acta, vol. 388, no. 1-2, pp. 78–83, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. J. Delgado-Lista, F. Perez-Jimenez, J. Ruano et al., “Effects of variations in the APOA1/C3/A4/A5 gene cluster on different parameters of postprandial lipid metabolism in healthy young men,” Journal of Lipid Research, vol. 51, no. 1, pp. 63–73, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. K. L. Chien, W. H. Fang, H. C. Wen et al., “APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese,” Clinica Chimica Acta, vol. 390, no. 1-2, pp. 56–62, 2008. View at Publisher · View at Google Scholar · View at Scopus
  23. J. A. Hubacek, R. Bohuslavova, Z. Skodova, J. Pitha, D. Bobkova, and R. Poledne, “Polymorphisms in the APOA1/C3/A4/A5 gene cluster and cholesterol responsiveness to dietary change,” Clinical Chemistry and Laboratory Medicine, vol. 45, no. 3, pp. 316–320, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ashokkumar, N. G. V. Subhashini, R. Saibabu, A. Ramesh, K. M. Cherian, and C. Emmanuel, “Genetic variants on apolipoprotein gene cluster influence triglycerides with a risk of coronary artery disease among Indians,” Molecular Biology Reports, vol. 37, no. 1, pp. 521–527, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. Z. K. Liu, M. Hu, L. Baum, G. N. Thomas, and B. Tomlinson, “Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese,” Atherosclerosis, vol. 208, no. 2, pp. 427–432, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. E. A. Ruiz-Narváez, Y. Yang, Y. Nakanishi, J. Kirchdorfer, and H. Campos, “APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica,” Journal of Lipid Research, vol. 46, no. 12, pp. 2605–2613, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. M. Fiegenbaum, F. M. de Andrade, and M. H. Hutz, “Association between plasma lipid parameters and APOC3 genotypes in Brazilian subjects: effect of gender, smoking and APOE genotypes,” Clinica Chimica Acta, vol. 380, no. 1-2, pp. 175–181, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. H. Jakel, M. Nowak, A. Helleboid-Chapman, J. Fruchart-Najib, and J. C. Fruchart, “Is apolipoprotein A5 a novel regulator of triglyceride-rich lipoproteins?” Annals of Medicine, vol. 38, no. 1, pp. 2–10, 2006. View at Publisher · View at Google Scholar · View at Scopus